KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
76,27 US$
arrow_downward
-0,27%(-0,21) 1D
76,27 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 11 სექ, 16:00:01 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
77,70 US$
High
78,59 US$
Low
76,14 US$
Mkt. cap
5,95 მლრდ.
Avg. vol.
504,57 ათ.
Volume
576,56 ათ.
P/E ratio
77,59
52-wk high
82,94 US$
52-wk low
35,20 US$
EPS
0,98 US$
Beta
0,09
Shares outstanding
48,29 მლნ.
No. of employees
366
Open
77,70 US$
High
78,59 US$
Low
76,14 US$
Mkt. cap
5,95 მლრდ.
Avg. vol.
504,57 ათ.
Volume
576,56 ათ.
P/E ratio
77,59
52-wk high
82,94 US$
52-wk low
35,20 US$
EPS
0,98 US$
Beta
0,09
Shares outstanding
48,29 მლნ.
No. of employees
366
News stories
From web sources and news partners
Investor's Business Daily
·
3 დღის წინ
Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat
https://www.dars.gov.et/
·
3 თვის წინ
Kiniksa Pharmaceuticals (KNSA) Q1 2026 Earnings: EPS Surges Past Expectations by 31.5%, Stock Edges Lower - Pretax Income Report
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquartersლონდონი, ინგლისი, გაერთიანებული სამეფო
Sector-
Websitekiniksa.com